» Articles » PMID: 2261644

Mutations in V-myb Alter the Differentiation of Myelomonocytic Cells Transformed by the Oncogene

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 1990 Dec 21
PMID 2261644
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Chick myelomonocytic cells transformed by the v-myb oncogene-containing viruses E26 and AMV differ in that the former resemble myeloblasts and express the v-myb-regulated granulocyte-specific mim-1 gene, while the latter resemble monoblasts and are mim-1 negative. We constructed a series of AMV-E26 chimeras and localized the critical differences between these viruses to three point mutations within the second repeat of the v-myb DNA binding domain. These three positions are altered in the v-myb protein of AMV relative to the proteins encoded by c-myb or E26 v-myb. Back mutating AMV v-myb at any of these three sites restored the oncogene's ability to activate the mim-1 gene. Surprisingly, two of these changes led to the transformation, in vitro and in vivo, of cells having a promyelocyte-like phenotype. These results indicate that different forms of v-myb impose alternate phenotypes of differentiation on transformed myeloid cells, probably by regulating unique sets of differentiation-specific genes.

Citing Articles

MYB as a Critical Transcription Factor and Potential Therapeutic Target in AML.

Clarke M, Gabrielsen O, Frampton J Adv Exp Med Biol. 2024; 1459:341-358.

PMID: 39017851 DOI: 10.1007/978-3-031-62731-6_15.


Dominant Gene Expression Profiles Define Adenoid Cystic Carcinoma (ACC) from Different Tissues: Validation of a Gene Signature Classifier for Poor Survival in Salivary Gland ACC.

Brayer K, Kang H, El-Naggar A, Andreasen S, Homoe P, Kiss K Cancers (Basel). 2023; 15(5).

PMID: 36900183 PMC: 10000625. DOI: 10.3390/cancers15051390.


MYB oncoproteins: emerging players and potential therapeutic targets in human cancer.

Ciciro Y, Sala A Oncogenesis. 2021; 10(2):19.

PMID: 33637673 PMC: 7910556. DOI: 10.1038/s41389-021-00309-y.


N-Terminal Truncated Myb with New Transcriptional Activity Produced Through Use of an Alternative MYB Promoter in Salivary Gland Adenoid Cystic Carcinoma.

Frerich C, Sedam H, Kang H, Mitani Y, El-Naggar A, Ness S Cancers (Basel). 2019; 12(1).

PMID: 31877778 PMC: 7016764. DOI: 10.3390/cancers12010045.


MYB - A regulatory factor in hematopoiesis.

Wang X, Angelis N, Thein S Gene. 2018; 665:6-17.

PMID: 29704633 PMC: 10764194. DOI: 10.1016/j.gene.2018.04.065.